Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors

Liver Transplantation

Volumn 22, Issue 3, 2016, Pages 377-

  Tandoi, Francesco ^a   Salizzoni, Mauro ^a   Brunati, Andrea ^a   Lupo, Francesco ^a   Romagnoli, Renato ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BRAIN GRAFT; CANCER SURGERY; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LETTER; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; BRAIN; BRAIN DEATH; DONOR; FATTY LIVER; LIVER;

BRAIN; BRAIN DEATH; FATTY LIVER; HUMANS; LIVER; LIVER TRANSPLANTATION; TISSUE DONORS;

EID: 84983215762     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24362     Document Type: Letter

References (3)

1. Wong TC, Fung JY, Chok KS, Cheung TT, Chan AC, Sharr WW, et al., Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors. Liver Transpl 2016; 22: 226-236.
2. Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, et al., Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010; 16: 943-949.
3. Salizzoni M, Franchello A, Zamboni F, Ricchiuti A, Cocchis D, Fop F, et al., Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 2003; 16: 486-493.